Annual Working Capital
$46.60 M
-$142.02 M-75.30%
31 December 2023
Summary:
Sangamo Therapeutics annual working capital is currently $46.60 million, with the most recent change of -$142.02 million (-75.30%) on 31 December 2023. During the last 3 years, it has fallen by -$469.52 million (-90.97%). SGMO annual working capital is now -90.97% below its all-time high of $516.12 million, reached on 31 December 2020.SGMO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$14.97 M
+$13.90 M+1299.07%
30 September 2024
Summary:
Sangamo Therapeutics quarterly working capital is currently $14.97 million, with the most recent change of +$13.90 million (+1299.07%) on 30 September 2024. Over the past year, it has dropped by -$84.12 million (-84.89%). SGMO quarterly working capital is now -97.44% below its all-time high of $585.46 million, reached on 30 June 2020.SGMO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.3% | -84.9% |
| 3 y3 years | -91.0% | -95.3% |
| 5 y5 years | -86.0% | -95.1% |
SGMO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -91.0% | at low | -95.3% | +1299.1% |
| 5 y | 5 years | -91.0% | at low | -97.4% | +1299.1% |
| alltime | all time | -91.0% | +547.2% | -97.4% | +1299.1% |
Sangamo Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.97 M(+1299.1%) |
| June 2024 | - | $1.07 M(-96.2%) |
| Mar 2024 | - | $28.39 M(-39.1%) |
| Dec 2023 | $46.60 M(-75.3%) | $46.60 M(-53.0%) |
| Sept 2023 | - | $99.09 M(-6.4%) |
| June 2023 | - | $105.82 M(-37.5%) |
| Mar 2023 | - | $169.25 M(-10.3%) |
| Dec 2022 | $188.62 M(-30.4%) | $188.62 M(-12.0%) |
| Sept 2022 | - | $214.26 M(-4.0%) |
| June 2022 | - | $223.13 M(+0.7%) |
| Mar 2022 | - | $221.54 M(-18.2%) |
| Dec 2021 | $270.88 M(-47.5%) | $270.88 M(-14.1%) |
| Sept 2021 | - | $315.50 M(-24.4%) |
| June 2021 | - | $417.12 M(-12.0%) |
| Mar 2021 | - | $474.11 M(-8.1%) |
| Dec 2020 | $516.12 M(+53.8%) | $516.12 M(-10.5%) |
| Sept 2020 | - | $576.73 M(-1.5%) |
| June 2020 | - | $585.46 M(+89.5%) |
| Mar 2020 | - | $308.88 M(-8.0%) |
| Dec 2019 | $335.60 M(+1.1%) | $335.60 M(+10.5%) |
| Sept 2019 | - | $303.63 M(-20.0%) |
| June 2019 | - | $379.76 M(+39.9%) |
| Mar 2019 | - | $271.50 M(-18.2%) |
| Dec 2018 | $332.01 M(+63.1%) | $332.01 M(-15.8%) |
| Sept 2018 | - | $394.08 M(-16.9%) |
| June 2018 | - | $474.10 M(+153.7%) |
| Mar 2018 | - | $186.89 M(-8.2%) |
| Dec 2017 | $203.54 M(+49.3%) | $203.54 M(+2.1%) |
| Sept 2017 | - | $199.40 M(-6.8%) |
| June 2017 | - | $214.02 M(+77.3%) |
| Mar 2017 | - | $120.71 M(-11.4%) |
| Dec 2016 | $136.29 M(-29.2%) | $136.29 M(+1.0%) |
| Sept 2016 | - | $134.98 M(-16.5%) |
| June 2016 | - | $161.69 M(-10.7%) |
| Mar 2016 | - | $181.04 M(-5.9%) |
| Dec 2015 | $192.49 M(+13.2%) | $192.49 M(-6.4%) |
| Sept 2015 | - | $205.56 M(+2.8%) |
| June 2015 | - | $199.95 M(+8.7%) |
| Mar 2015 | - | $183.98 M(+8.2%) |
| Dec 2014 | $170.00 M(+95.1%) | $170.00 M(+10.6%) |
| Sept 2014 | - | $153.68 M(-17.5%) |
| June 2014 | - | $186.18 M(-8.6%) |
| Mar 2014 | - | $203.81 M(+133.9%) |
| Dec 2013 | $87.14 M(+46.3%) | $87.14 M(-26.9%) |
| Sept 2013 | - | $119.14 M(+155.3%) |
| June 2013 | - | $46.67 M(-16.1%) |
| Mar 2013 | - | $55.59 M(-6.7%) |
| Dec 2012 | $59.58 M | $59.58 M(+5.7%) |
| Sept 2012 | - | $56.37 M(-2.0%) |
| June 2012 | - | $57.51 M(-24.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $76.21 M(-2.9%) |
| Dec 2011 | $78.49 M(+44.8%) | $78.49 M(-4.9%) |
| Sept 2011 | - | $82.56 M(-8.3%) |
| June 2011 | - | $90.02 M(+102.2%) |
| Mar 2011 | - | $44.52 M(-17.9%) |
| Dec 2010 | $54.22 M(-22.7%) | $54.22 M(-9.4%) |
| Sept 2010 | - | $59.84 M(-10.1%) |
| June 2010 | - | $66.60 M(-2.2%) |
| Mar 2010 | - | $68.12 M(-2.8%) |
| Dec 2009 | $70.12 M(+29.3%) | $70.12 M(+64.0%) |
| Sept 2009 | - | $42.75 M(-5.9%) |
| June 2009 | - | $45.43 M(-6.3%) |
| Mar 2009 | - | $48.47 M(-10.6%) |
| Dec 2008 | $54.22 M(-25.1%) | $54.22 M(-1.5%) |
| Sept 2008 | - | $55.06 M(-10.2%) |
| June 2008 | - | $61.34 M(-7.2%) |
| Mar 2008 | - | $66.13 M(-8.7%) |
| Dec 2007 | $72.44 M(+45.3%) | $72.44 M(-5.9%) |
| Sept 2007 | - | $76.95 M(+94.9%) |
| June 2007 | - | $39.48 M(-12.1%) |
| Mar 2007 | - | $44.91 M(-9.9%) |
| Dec 2006 | $49.86 M(+19.7%) | $49.86 M(-5.8%) |
| Sept 2006 | - | $52.90 M(-5.0%) |
| June 2006 | - | $55.69 M(+44.1%) |
| Mar 2006 | - | $38.64 M(-7.3%) |
| Dec 2005 | $41.67 M(+30.1%) | $41.67 M(+88.8%) |
| Sept 2005 | - | $22.07 M(-13.5%) |
| June 2005 | - | $25.52 M(-11.3%) |
| Mar 2005 | - | $28.76 M(-10.2%) |
| Dec 2004 | $32.03 M(-26.7%) | $32.03 M(-7.3%) |
| Sept 2004 | - | $34.55 M(-10.8%) |
| June 2004 | - | $38.75 M(-6.8%) |
| Mar 2004 | - | $41.58 M(-4.9%) |
| Dec 2003 | $43.71 M(-16.1%) | $43.71 M(-2.4%) |
| Sept 2003 | - | $44.80 M(-4.6%) |
| June 2003 | - | $46.96 M(-5.2%) |
| Mar 2003 | - | $49.53 M(-5.0%) |
| Dec 2002 | $52.12 M(-14.7%) | $52.12 M(-0.2%) |
| Sept 2002 | - | $52.20 M(-4.7%) |
| June 2002 | - | $54.78 M(-5.2%) |
| Mar 2002 | - | $57.77 M(-5.4%) |
| Dec 2001 | $61.10 M(-5.2%) | $61.10 M(-3.4%) |
| Sept 2001 | - | $63.24 M(+3.0%) |
| June 2001 | - | $61.38 M(-2.8%) |
| Mar 2001 | - | $63.12 M(-2.1%) |
| Dec 2000 | $64.48 M(+795.5%) | $64.48 M(+31.5%) |
| Sept 2000 | - | $49.02 M(-11.2%) |
| June 2000 | - | $55.21 M(+169.9%) |
| Mar 2000 | - | $20.46 M |
| Dec 1999 | $7.20 M | - |
FAQ
- What is Sangamo Therapeutics annual working capital?
- What is the all time high annual working capital for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual working capital year-on-year change?
- What is Sangamo Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly working capital year-on-year change?
What is Sangamo Therapeutics annual working capital?
The current annual working capital of SGMO is $46.60 M
What is the all time high annual working capital for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual working capital is $516.12 M
What is Sangamo Therapeutics annual working capital year-on-year change?
Over the past year, SGMO annual working capital has changed by -$142.02 M (-75.30%)
What is Sangamo Therapeutics quarterly working capital?
The current quarterly working capital of SGMO is $14.97 M
What is the all time high quarterly working capital for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly working capital is $585.46 M
What is Sangamo Therapeutics quarterly working capital year-on-year change?
Over the past year, SGMO quarterly working capital has changed by -$84.12 M (-84.89%)